Morepen Share Price Target 2025 To 2030 – Risk And Challenges For Morepen Share Price

Morepen Share Price Target

Morepen Laboratories Limited, a pharmaceutical company founded on December 1st 1984, develops, manufactures and markets generic drugs and pharmaceutical formulations for domestic and international customers. The Company offers products in different forms, such as tablets, capsules, injections, ointments, syrups, and powders. The company is headquartered in New Delhi. Morepen Share Price on NSE as of 21 January 2025 is 68.36 INR.

Morepen Share Price Current Market Overview

  • Today’s  Open: 70.93
  • Today’s  High: 71.32
  • Today’s  Low: 68.12
  • Current Share Price:68.36
  • Market Capital: 3.78KCr
  • P/E Raito:26.91
  • Dividend Yield: N/A
  • 52 Week High: 100.90
  • 52 Week Low: 38.55

Morepen Share Price Chart

Morepen Share Price Chart

Morepen Share Price Target Tomorrow From 2025 To 2030

The following table shows the share target price for upcoming years, which is based on market valuation, industrial trends, and expert predictions:

      Sr.No.       Year Share Price Target
1 2025 Rs 110
2 2026 Rs 150
3 2027 Rs 215
4 2028 Rs 262
5 2029 Rs 325
6 2030 Rs 385

Shareholding Pattern For Morepen Share Price

Morepen Laboratories has a numerous shareholding structure that shows market self-notion and investor hobby:

  • Retail and Others: 53.73 %
  • Promoters: 35.65 %
  • Foreign Institutions: 7.72 %
  • Other Domestic Institutions: 2.90%

Morepen Share Price Annual Income Statement

The given chart shows the comparison between revenue and net income.

Morepen Share Price Annual Income Statement

Here are the details of the company’s annual income statement.

Particulars Info 2024 Y/Y Change
Revenue 4.59B 13.68%(+)
Operating Expenses 1.17B 2.26%(+)
Net Income 361.68M 147.16% (+)
Net Profit Margin 7.89 117.36% (+)
Earning Per Share N/A N/A
EBITDA 537.86M 93.64% (+)
Effective Tax Rate 24.91% N/A

Risk And Challenges For Morepen Share Price

While the Morepen Share Price is positive, several dangers and challenges may additionally moreover want to impact its growth:

  • Currency Fluctuation: As Morepen expands its global presence, it will be exposed to currency risk that could affect its financial performance.
  • Market Competition: The pharmaceutical industry is highly competitive, with numerous players vying for market share. Morepen must continuously innovate and deliver high-quality products to maintain its position.
  • Regulatory Risk: Changes in domestic and international policies, especially within the pharmaceutical sector, can impact Morepen’s operation and profitability.
  • Dependency on Key Products: Morepen’s heavy reliance on specific APIs may pose a risk if demand for these products declines or if competitors introduce alternatives.

Read Also:- Siemens India Share Price Target Tomorrow 2025 To 2030- Prediction, Market Overview

Leave a Comment

Your email address will not be published. Required fields are marked *